Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis von Ferreira, A.R., Di Meglio, A., Pistilli, B., Gbenou, A.S., El-Mouhebb, M., Dauchy, S., Charles, C., Joly, F., Everhard, S., Lambertini, M., Coutant, C., Cottu, P., Lerebours, F., Petit, T., Dalenc, F., Rouanet, P., Arnaud, A., Martin, A., Berille, J., Ganz, P.A., Partridge, A.H., Delaloge, S., Michiels, S., Andre, F., Vaz-Luis, I.

Volltext

Survival of breast cancer patients with meningeal carcinomatosis von Gauthier, H., Guilhaume, M.N., Bidard, F.C., Pierga, J.Y., Girre, V., Cottu, P.H., Laurence, V., Livartowski, A., Mignot, L., Diéras, V.

Volltext

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1) von Bonnefoi, H., Grellety, T., Tredan, O., Saghatchian, M., Dalenc, F., Mailliez, A., L'Haridon, T., Cottu, P., Abadie-Lacourtoisie, S., You, B., Mousseau, M., Dauba, J., Del Piano, F., Desmoulins, I., Coussy, F., Madranges, N., Grenier, J., Bidard, F.C., Proudhon, C., MacGrogan, G., Orsini, C., Pulido, M., Gonçalves, A.

Volltext

Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ von Fancellu, A., Turner, R. M., Dixon, J. M., Pinna, A., Cottu, P., Houssami, N.

Volltext

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer von Cottu, P., D'Hondt, V., Dureau, S., Lerebours, F., Desmoulins, I., Heudel, P.-E., Duhoux, F.P., Levy, C., Mouret-Reynier, M.-A., Dalenc, F., Frenel, J.-S., Jouannaud, C., Venat-Bouvet, L., Nguyen, S., Ferrero, J.-M., Canon, J.-L., Grenier, J., Callens, C., Gentien, D., Lemonnier, J., Vincent-Salomon, A., Delaloge, S.

Volltext

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort von Grinda, T., Antoine, A., Jacot, W., Blaye, C., Cottu, P.-H., Diéras, V., Dalenc, F., Gonçalves, A., Debled, M., Patsouris, A., Mouret-Reynier, M.-A., Mailliez, A., Clatot, F., Levy, C., Ferrero, J.-M., Desmoulins, I., Uwer, L., Petit, T., Jouannaud, C., Lacroix-Triki, M., Deluche, E., Robain, M., Courtinard, C., Bachelot, T., Brain, E., Pérol, D., Delaloge, S.

Volltext

Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience von Staudacher, L., Cottu, P.H., Diéras, V., Vincent-Salomon, A., Guilhaume, M.N., Escalup, L., Dorval, T., Beuzeboc, P., Mignot, L., Pierga, J.Y.

Volltext

Radiotherapy and targeted therapy for the management of breast cancer: A review von Beddok, A, Cottu, P, Fourquet, A, Kirova, Y

Volltext

Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer von Hamy, A.-S., Pierga, J.-Y., Sabaila, A., Laas, E., Bonsang-Kitzis, H., Laurent, C., Vincent-Salomon, A., Cottu, P., Lerebours, F., Rouzier, R., Lae, M., Reyal, F.

Volltext

A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later von Di Meglio, A., Havas, J., Pagliuca, M., Franzoi, M.A., Soldato, D., Chiodi, C.K., Gillanders, E., Dubuisson, F., Camara-Clayette, V., Pistilli, B., Ribeiro, J., Joly, F., Cottu, P.H., Tredan, O., Bertaut, A., Ganz, P.A., Bower, J., Partridge, A.H., Martin, A.L., Everhard, S., Boyault, S., Brutin, S., André, F., Michiels, S., Pradon, C., Vaz-Luis, I.

Volltext

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer von Porte, B., Carton, M., Lerebours, F., Brain, E., Loirat, D., Haroun, L., Bellesoeur, A., Bach Hamba, S., Kirova, Y., Cottu, P.

Volltext

Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum–paclitaxel-based chemotherapy, the GINECO experience von Alexandre, J., Ray-Coquard, I., Selle, F., Floquet, A., Cottu, P., Weber, B., Falandry, C., Lebrun, D., Pujade-Lauraine, E.

Volltext

Biological, preclinical and clinical aspects of the association between radiation therapy and CDK4/6 inhibitors von Beddok, A, Porte, B, Cottu, P, Fourquet, A, Kirova, Y

Volltext

Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program von Bello Roufai, D., Gonçalves, A., De La Motte Rouge, T., Akla, S., Blonz, C., Grenier, J., Gligorov, J., Saghatchian, M., Bailleux, C., Simon, H., Desmoulins, I., Tharin, Z., Renaud, E., Bertho, M., Benderra, M-A, Delaloge, S., Robert, L., Cottu, P., Pierga, J. Y., Loirat, D., Bertucci, A., Renouf, B., Bidard, F. C., Lerebours, F.

Volltext

Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study von Pivot, X., Spano, J.P., Espie, M., Cottu, P., Jouannaud, C., Pottier, V., Moreau, L., Extra, J.M., Lortholary, A., Rivera, P., Spaeth, D., Attar-Rabia, H., Benkanoun, C., Dima-Martinez, L., Esposito, N., Gligorov, J.

Volltext

Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series von Rodrigues, M.J., Peron, J., Frénel, J.-S., Vano, Y.-A., Wassermann, J., Debled, M., Picaud, F., Albiges, L., Vincent-Salomon, A., Cottu, P.H.

Volltext

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients von Jacquet, E., Lardy-Cléaud, A., Pistilli, B., Franck, S., Cottu, P., Delaloge, S., Debled, M., Vanlemmens, L., Leheurteur, M., Guizard, A.V., Laborde, L., Uwer, L., Jacot, W., Berchery, D., Desmoulins, I., Ferrero, J.M., Perrocheau, G., Courtinard, C., Brain, E., Chabaud, S., Robain, M., Bachelot, T.

Volltext

Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list von Rault, A, Dolbeault, S, Terrasson, J, Bouleuc, C, Cottu, P, Piperno-Neumann, S, Rodrigues, M, Vaflard, P, Brédart, A

Volltext

Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ov... von Konecny, G.E., Hendrickson, A.E. Wahner, Davidson, T.M., Winterhoff, B.J., Ma, S., Mahner, S., Sehouli, J., Fasching, P.A., Feisel-Schwickardi, G., Poelcher, M., Roman, L.D., Rody, A., Karlan, B.Y., Mullany, S.A., Chen, H., Ray-Coquard, I.L., Provencher, D.M., Yachnin, A., Cottu, P.H., Glaspy, J.A., Haluska, P., Slamon, D.J.

Volltext

Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts von Cottu, P., Marangoni, E., Assayag, F., de Cremoux, P., Vincent-Salomon, A., Guyader, Ch, de Plater, L., Elbaz, C., Karboul, N., Fontaine, J. J., Chateau-Joubert, S., Boudou-Rouquette, P., Alran, S., Dangles-Marie, V., Gentien, D., Poupon, M.-F., Decaudin, D.

Volltext